Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3721 Target Snapshot

Cytochrome P450 2C8 · SINGLE PROTEIN · Homo sapiens

1,404Compounds
773Assays
23Approved Drugs
1,090.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P10632. Use UniProt P10632 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P10632 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Cytochrome P450 2C8 as ChEMBL target CHEMBL3721, mapped to UniProt P10632. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Cytochrome P450 2C8
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL3721
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P10632
Cytochrome P450 2C8
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Cytochrome P450 2C8 is the right protein anchor across sources, using UniProt P10632 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCytochrome P450 2C8
UniProt AccessionP10632
Component TypeProtein
Sequence Length490 aa

Cytochrome P450 2C8

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Cytochrome P450 2C8, mapped to UniProt P10632. Sequence length is 490 aa.

Mapped IDP10632
Review nameCytochrome P450 2C8
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

23
Approved
5
Phase III
20
Phase II
12
Phase I
Assay Mix

Activity Type Distribution

IC501,065.0
KI23.0
KD2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4577468 8.6 IC50 2.5 Preclinical
CHEMBL4066318 7.66 Ki 22.0 Preclinical
CHEMBL4086080 7.58 IC50 26.0 Preclinical
CHEMBL2036213 7.37 IC50 43.0 Preclinical
CHEMBL2036225 7.3 IC50 50.0 Preclinical
CHEMBL2036220 7.27 IC50 54.0 Preclinical
CHEMBL2036222 7.1 IC50 79.0 Preclinical
CHEMBL4446613 7.1 IC50 79.43 Preclinical
CHEMBL2036210 7.07 IC50 86.0 Preclinical
CHEMBL4242598 7.0 IC50 100.0 Preclinical
Distribution

pChEMBL Value Distribution

153
5.0
92
5.5
41
6.0
15
6.5
9
7.0
2
7.5
0
8.0
1
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

RESMETIROM
CHEMBL3261331
Approved 2024
MONTELUKAST
CHEMBL787
Approved 1998
CLOTRIMAZOLE
CHEMBL104
Approved 1975
Assay Landscape

Assay Landscape

773
Total Assays
412
Tested Compounds
3
Assay Types
ADME — 755 assays, 412 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 409 188 5.4
microsome format 185 157 5.2
assay format 123 66 5.3
cell-based format 28 1 5.0
tissue-based format 10 0
Binding — 17 assays, 63 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 7 36 4.9
single protein format 6 4 5.4
tissue-based format 4 23 5.4
Toxicity — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
microsome format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine